Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06419309
Other study ID # HUSBFBVDBE001
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 15, 2024
Est. completion date August 15, 2025

Study information

Verified date May 2024
Source Halic University
Contact Berrak Basturk, Lecturer
Phone 05465088090
Email berrakerguden@halic.edu.tr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Hashimoto's thyroiditis (HT) is the most common cause of chronic hypothyroidism in areas with sufficient iodine, stemming from an autoimmune response against thyroid peroxidase and/or thyroglobulin. It is the most prevalent autoimmune thyroid disease and a leading cause of overall hypothyroidism. Even when they reach euthyroidism, 82% of treated women with HT still have excess body weight, and 35% of them are obese. Thyroid dysfunction can affect the function of adipose tissue and lead to metabolic disturbances. Leptin can stimulate thyroid-stimulating hormone secretion, while thyroid-stimulating hormone can influence leptin release from adipose tissue. Additionally, HT patients often exhibit high levels of C-reactive protein and interleukin-6, suggesting an association between increased thyroid-stimulating hormone levels and the inflammatory process, which may contribute to comorbid disease risk in individuals with HT. Nutrition can serve as a complementary treatment for HT by affecting thyroid functions and having anti-inflammatory properties. Dietary interventions may involve eliminating gluten, lactose, or certain food components, or focusing on an anti-inflammatory dietary pattern while preventing nutritional deficiencies. Therefore, this study is a randomized controlled, single-blind trial designed to evaluate the effects of a gluten-free, lactose-free diet and a diet enriched with Aronia Melanocarpa, both individually and in combination, as well as healthy dietary protocols, on autoantibody levels, leptin, ghrelin, oxidative response, and weight loss in patients with Hashimoto's thyroiditis. The study aims to recruit a minimum of 80 participants aged 18-65 years, diagnosed with Hashimoto's thyroiditis at Istanbul Medical Faculty Hospital. In the initial face-to-face interview, participants will provide sociodemographic information, dietary habits, anthropometric measurements, and dietary intake records through a questionnaire. The study involves the inclusion of Aronia Melanocarpa in the diet (high anthocyanin content, 69.24 mg/100 ml), a gluten-free and lactose-free diet, both interventions being applied together, and the application of only healthy nutrition protocols to patients over an 8-week period, with serum assessments of thyroid-stimulating hormon, free T4, free T3, anti-thyroid peroxidase, anti-Tg, interleukin-6,anti tumor necrosis factor alpha, C-reactive protein and leptin-ghrelin levels at the beginning and end of the study. The goal is to create recommendations for patients, improve their quality of life, and establish sustainable nutritional interventions.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 80
Est. completion date August 15, 2025
Est. primary completion date May 15, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Being diagnosed with Hashimoto's thyroiditis by a doctor, - Being a female individual between the ages of 18-65, - Not being diagnosed with any chronic disease that would negatively affect functioning other than Hashimoto's thyroid, - Not having used selenium and iodine supplements in the last month, - Individuals should not lose more than 4 kg of weight in the last month, - Not having been on a strict elimination diet for more than 4 months in the last year, - Not having applied any nutritional intervention during the last three months before the study. Exclusion Criteria: - Pregnant or breastfeeding mother, - Individuals with chronic diseases, - Individuals allergic to red fruits

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Dietary intervention
Four different dietary interventions are planned. Gluten-free, lactose-free diet, Diet enriched with Aronia Melanocarpa, Gluten-free, lactose-free and enriched with Aronia Melanocarpa diet, Healthy diet

Locations

Country Name City State
Turkey Halic University Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Halic University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effect of diet on weight loss The effect of diets on weight loss will be evaluated. Body composition analyzes of individuals (body weight (kg), body fat ratio (%), body water ratio (%), visceral fat ratio) will be performed using handheld device. Start and end of study (8 weeks)
Primary Effect of diet on hormone level The effects of diets on leptin and ghrelin levels will be examined with venous blood samples. Start and end of study (8 weeks)
Primary Effect of diet on inflammatory parameters To evaluate oxidative stress parameters, two 5 mL venous blood samples will be taken from each patient in yellow tubes after an overnight fast of at least eight hours between 08:00 and 09:00 in the morning.
The blood sample will be kept at room temperature for 10-20 minutes and after being centrifuged at 2000-3000 rpm for 20 minutes, it will be transferred to Eppendorf tubes with the help of a sterile pipette and will be stored in 2 separate refrigerators at -20 °C.
IL-6, TNF-alpha, CRP levels will be measured with commercial kits, following the company protocol.
Start and end of study (8 weeks)
Secondary Effect of diet on routine hashimoto thyroid parameters Thyroid Stimulating Hormone, free thyroxine, free triiodothyronine, thyroid peroxidase antibodies and anti-thyroglobulin biochemical parameters of the participants will be requested by the doctor with institutional permission and patient approval. Start and end of study (8 weeks)
See also
  Status Clinical Trial Phase
Completed NCT02491567 - DNA Methylation and Autoimmune Thyroid Diseases
Completed NCT01760421 - The Effect of Hydroxychloroquine Treatment in Hashimoto's Thyroiditis N/A
Completed NCT04239521 - The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
Completed NCT01884649 - Fetuin A in Hashimoto Thyroiditis N/A
Completed NCT05949671 - Evaluation of the Effect of Gluten-Free Diet and Mediterranean Diet N/A
Not yet recruiting NCT05871957 - Adjuvant Therapeutic Effect of Vitamin D on Hashimoto's Thyroiditis
Completed NCT01270425 - Sonographic and Laboratory Evaluation of the Thyroid Gland in Patients With Systemic Sclerosis N/A
Completed NCT03941184 - Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
Completed NCT04754607 - Effects of Low-Level Laser Therapy on Oxidative Stress Levels... N/A